Using a common antibiotic following sex can dramatically reduce a person's risk of some sexually transmitted infections, a ...
Both studies in JAMA Internal Medicine supported the rising profile of doxyPEP as a way to counter the epidemic of syphilis, gonorrhea, and chlamydia infections, even if the data ...
While the use of PrEP has helped drop the rates of HIV infections, instances of syphilis and chlamydia among queer men have ...
The early rollout of doxyPEP — a dose of the antibiotic doxycycline after sex — has contributed to a decline in sexually ...
A new study tracked thousands of gay men taking PrEP and DoxyPEP. A new study tracked thousands of gay men taking PrEP and ...
It was published on Jan. 6 in JAMA Internal Medicine. DoxyPEP is a new strategy for preventing STIs that involves taking a dose of doxycycline, a common and well-tolerated antibiotic medication, ...
Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...
A new study in JAMA Internal Medicine led by the Harvard Pilgrim Health Care Institute examined whether doxycycline post-exposure prophylaxis (doxyPEP) was associated with declines in bacterial ...
A new treatment for sexually-transmitted diseases seems to be slowing an STI epidemic — but not everyone can get it ...
Taking doxycycline within 72 hours after sex reduced risk of chlamydia by 79%, syphilis by 80%, and gonorrhea by 12%, results published in JAMA Internal Medicine show. Adobe Stock Worried about ...